Dla naukowców
J.R. Best, T. Liu-Ambrose, A.L. Metti, et al.J Gerontol A Biol Sci Med Sci. 2018;73(9):1265-1271 In this longitudinal study, we hypothesized that early mobility limitations would contribute to later decreases in physical activity to a larger degree than the reciprocal association of early decreases in physical activity to later mobility limitations. |
A.A. ZulfiqarGeriatr Psychol Neuropsychiatr Vieil. 2018;16(3):269-277 A prospective, observational study was performed in subjects aged over 75 years, coming from the first neuro-geriatric consultation, from July 3, 2017 to August 18, 2017, included in the CHU Rouen, and benefiting from frailty screening through the use of the grid SEGAm (part A); this correlated with the subjective opinion of the nurse. |
M. Yang, X. Hu, L. Xie, et al.J Am Med Dir Assoc. 2018 Jun 13. pii: S1525-8610(18)30229-9. doi: 10.1016/j.jamda.2018.04.012. [Epub ahead of print] The Mini Sarcopenia Risk Assessment (MSRA), a new sarcopenia screening tool, has 2 versions: MSRA-7 (full version, 7 items) and MSRA-5 (short version, 5 items). We aimed to compare the diagnostic values of MSRA-7 and MSRA-5 to SARC-F for screening sarcopenia. |
M. Yang, X. Hu, L. Xie, et al.Medicine (Baltimore). 2018;97(30):e11726 A 3-item SARC-F (termed SARC-F-3 in our study) was recently suggested as a screening tool for sarcopenia. The aim of this study was to compare the diagnostic value of SARC-F-3 to SARC-F in community-dwelling older people. |
J. Viña, C. Borras and M.C. Gomez-CabreraFree Radic Biol Med. 2018 Jun 26;124:358-363 In this review, we describe results from both, experimental animals and human cohorts, that lead us to the formulate this free radical theory of frailty. |
D.J. Wilkinson, M. Piasecki and P.J. AthertonAgeing Res Rev. 2018;47:123-132 This review will focus on muscle deterioration with ageing and highlight the two underpinning mechanisms regulating declines in muscle mass and function: muscle fibre atrophy and muscle fibre loss (hypoplasia) - and their measurement. |



